The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: A multicenter, multicohort clinical trial (ALTER-G-001).
 
Jing Liu
No Relationships to Disclose
 
Junwei Wu
No Relationships to Disclose
 
Liangjun Zhu
No Relationships to Disclose
 
Jun Yan
No Relationships to Disclose
 
Yong Mao
No Relationships to Disclose
 
Xinyu Tang
No Relationships to Disclose
 
Lingjun Zhu
No Relationships to Disclose
 
Hong Jiang
No Relationships to Disclose
 
Xiaowei Wei
No Relationships to Disclose
 
Chengfang Shangguan
No Relationships to Disclose
 
Wenqi Xi
No Relationships to Disclose
 
Yan Shi
No Relationships to Disclose
 
Min Shi
No Relationships to Disclose
 
Chenfei Zhou
No Relationships to Disclose
 
Hui Yang
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose